[Fibrinolytic therapy for femoral artery thrombosis after left cardiac catheterization in children]

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Jun;38(6):518-21.
[Article in Chinese]

Abstract

Objective: The study was conducted to investigate the feasibility and effectiveness of fibrinolytic therapy for femoral artery thrombosis after left cardiac catheterization in children.

Methods: Thrombolytic therapy with urokinase was applied in 16 children (5 males) with femoral artery thrombosis after left cardiac catheterization. Patients were given a bolus injection of heparin, 100 U/kg. 30,000-100,000 U boluses of urokinase were injected intravenously, and then a continuous infusion of 10,000-50,000 U/h was started. Transcatheter thrombolysis was performed once previous procedures failed.

Results: All 16 patients presented lower limbs ischemia after left cardiac catheterizations. The age was (2.6 +/- 1.9) years, the height was (85.3 +/- 13.1) cm, the weight was (11.2 +/- 3.8) kg. Patients with cyanotic and acyanotic congenital heart disease were 2 and 14, respectively. Interventional therapy was performed in 12 patients. Absent arterial pulsations were found in 15 patients and reduced arterial pulsation in 1 patient. Femoral arterial perfusion became normal in all patients (3 after transcatheter thrombolysis, 11 post intravenous thrombolysis and 2 post intravenous heparin). The average doses of heparin and urokinase were (950 +/- 682) U and (295,357 +/- 198,770) U. The average duration of therapy was (7.25 +/- 5.31) h. Mild residual stenosis were found in 2 patients post various treatments.

Conclusion: Fibrinolytic therapy with urokinase is a safe and useful modality for children with femoral artery thrombosis after left cardiac catheterization.

Publication types

  • Evaluation Study

MeSH terms

  • Cardiac Catheterization / adverse effects
  • Child
  • Child, Preschool
  • Female
  • Femoral Artery
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / therapeutic use
  • Humans
  • Infant
  • Male
  • Postoperative Complications / drug therapy*
  • Thrombolytic Therapy*
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Heparin
  • Urokinase-Type Plasminogen Activator